Delivery Order SPE2DB24D2018-SPE2DB24FWUC3
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription medication RINVOQ ER 15 MG TABLET UU 30S. The contract, valued at $7,126.08, was awarded by the Defense Logistics Agency (DLA), a defense agency, on May 29, 2024, with a completion date of May 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp, a major...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract, with a ceiling value of $3,471.13, was awarded on May 28, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen, a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $9,313.41 and a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract is a Firm Fixed Price Delivery Order valued at $32,824.44, with a completion date of June 28, 2024. The awarding agency is the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds...
This federal contract award is to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, for the delivery of RINVOQ ER 15 MG TABLET UU 30S to the Department of Defense's Medical Supply Chain program. The $65,744.85 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) on September 11, 2024, with a completion date of September 12, 2024. The contract is not set aside for any specific business type. As a key supplier of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $6,015.42, is a delivery order issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $7,296.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of a pharmaceutical product, RINVOQ ER 15 MG TABLET, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $12,088.76 and a performance period through August 29, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a broad...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $6,015.42 firm fixed-price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award for $3,007.71 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier. The contract is for the delivery of RINVOQ ER 15 MG TABLET products, with a completion date of July 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds significant Indefinite Delivery Contracts...